Application

KITE

Kite Pharma, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97575775
Filing Date: 09/01/2022

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 97575775
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\975\757\97575775\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT KITE
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a stylized design of a kite adjacent to the word "Kite".
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 645 x 260
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Kite Pharma, Inc.
*MAILING ADDRESS 2400 Broadway
*CITY Santa Monica
*STATE
(Required for U.S. applicants)
California
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
90404
PHONE 650-574-3000
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION pharmaceutical preparations for use in the treatment of cancer and hematological diseases and disorders; biological preparations for use in the treatment of cancer and hematological diseases and disorders; pharmaceutical and biological preparations for immunotherapy, including cell therapy
FILING BASIS SECTION 1(a)
       FIRST USE ANYWHERE DATE At least as early as 08/22/2022
       FIRST USE IN COMMERCE DATE At least as early as 08/22/2022
       SPECIMEN FILE NAME(S) \\TICRS\EXPORT18\IMAGEOUT 18\975\757\97575775\xml1 \ APP0003.JPG
       SPECIMEN DESCRIPTION photograph of Applicant's product label
        WEBPAGE URL None Provided
        WEBPAGE DATE OF ACCESS None Provided
ATTORNEY INFORMATION
NAME Cynthia Smuzynska
ATTORNEY DOCKET NUMBER 09501-US-NF2
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Gilead Sciences, Inc.
STREET 333 Lakeside Drive
CITY Foster City
STATE California
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 94404
PHONE 650-522-5563
EMAIL ADDRESS trademarks@gilead.com
OTHER APPOINTED ATTORNEY Gretchen R. Stroud; Jack Wessel; Lori Mayall; Shelley Lai; Peter Colosi
CORRESPONDENCE INFORMATION
NAME Cynthia Smuzynska
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@gilead.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tmteams@gilead.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /cynthia smuzynska/
SIGNATORY'S NAME Cynthia Smuzynska
SIGNATORY'S POSITION Sr Counsel II, IP
SIGNATORY'S PHONE NUMBER 650-522-5563
DATE SIGNED 09/01/2022
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 97575775
Filing Date: 09/01/2022

To the Commissioner for Trademarks:

MARK: KITE (stylized and/or with design, see mark)
The literal element of the mark consists of KITE. The applicant is not claiming color as a feature of the mark. The mark consists of a stylized design of a kite adjacent to the word "Kite".
The applicant, Kite Pharma, Inc., a corporation of Delaware, having an address of
      2400 Broadway
      Santa Monica, California 90404
      United States
      650-574-3000(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  pharmaceutical preparations for use in the treatment of cancer and hematological diseases and disorders; biological preparations for use in the treatment of cancer and hematological diseases and disorders; pharmaceutical and biological preparations for immunotherapy, including cell therapy

In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 08/22/2022, and first used in commerce at least as early as 08/22/2022, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any item in the class of listed goods/services, consisting of a(n) photograph of Applicant's product label.
Specimen File1
Webpage URL: None Provided
Webpage Date of Access: None Provided




The owner's/holder's proposed attorney information: Cynthia Smuzynska. Other appointed attorneys are Gretchen R. Stroud; Jack Wessel; Lori Mayall; Shelley Lai; Peter Colosi. Cynthia Smuzynska of Gilead Sciences, Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      333 Lakeside Drive
      Foster City, California 94404
      United States
      650-522-5563(phone)
      trademarks@gilead.com
The docket/reference number is 09501-US-NF2.
Cynthia Smuzynska submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Cynthia Smuzynska
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmteams@gilead.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /cynthia smuzynska/   Date: 09/01/2022
Signatory's Name: Cynthia Smuzynska
Signatory's Position: Sr Counsel II, IP
Signatory's Phone Number: 650-522-5563
Signature method: Sent to third party for signature
Payment Sale Number: 97575775
Payment Accounting Date: 09/01/2022

Serial Number: 97575775
Internet Transmission Date: Thu Sep 01 19:56:51 ET 2022
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-202209011956516
36335-97575775-820b1807de86b1f16791aa3b5
2d38be19d8d48f1af0611a1a3d998c3dcce382d-
DA-56514080-20220901191921768709

Application [image/jpeg]

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed